US Patent Issued to Eagle Pharmaceuticals on March 24 for "Methods of treating severe acute respiratory syndrome" (New Jersey Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,633, issued on March 24, was assigned to Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.).

"Methods of treating severe acute respiratory syndrome" was invented by Adrian Hepner (Woodcliff Lake, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to methods of using dantrolene or a dantrolene prodrug, or a pharmaceutically acceptable salt thereof, to treat Severe Acute Respiratory Syndrome."

The patent was filed on April 8, 2021, under Application No. 17/995,604.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtm...